Check the latest share price of Lyka Labs, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹121.67
as on 04:01PM, 30 May 2025
NSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 10.27 % |
3 Month Return | + 19.97 % |
1 Year Return | + 12.4 % |
3 Year Return | + 1.05 % |
5 Year Return | + 658.07 % |
Market Stats | |
Previous Close | ₹123.63 |
Open | ₹123.96 |
Volume | 53.53K |
Upper Circuit | ₹148.35 |
Lower Circuit | ₹98.90 |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹434.24 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
54.81
Return on capital employed (ROCE)
0Industry PE ratio
56.12
Beta (LTM)
1.19
P/B Ratio
3.88
Dividend Yield
0PEG Ratio
8.78
Quarterly Earnings Growth YOY
-197.13
EPS (TTM)
-0.79
Sector
Pharmaceuticals
Book Value
17.86
Technical Analysis
Bullish
View Technical Analysis
Investing in Lyka Labs is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Lyka Labs or LYKALABS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Lyka Labs or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Lyka Labs with just a few clicks!
Track how the P/E of Lyka Labs has moved over time to understand valuation trends.
Lyka Labs in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (54.81x)
May 30, 2025
Industry (56.12x)
May 30, 2025
Highest (55.69x)
May 29, 2025
Today’s Price to Earnings Ratio: 54.81x
Get the annual and quarterly financial summary of Lyka Labs, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Lyka Labs.
Lyka Labs Ltd’s net profit jumped 197.13% since last year same period to ₹2.03Cr in the Q4 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated -24.81% fall in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lyka Labs.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 58.16% | 0.00 | |
Foreign Institutions | 0.23% | 0.00 | |
Mutual Funds | 0.01% | 0.00 | |
Retail Investors | 40.94% | 0.00 | |
Others | 0.66% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Lyka Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 434.24 | 131.61% | 0.69 | NA | NA | |
NA | 177.38 | 53.69% | 0.62 | NA | NA | |
NA | 19,930.00 | 31.61% | 0.51 | NA | NA | |
NA | 45.36 | 13.89% | 0.51 | NA | NA | |
NA | 1,054.86 | 25.92% | 0.51 | NA | NA |
Latest news and events at one place to help you take investing decisions in Lyka Labs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.15% to 0.23% in Mar 2025 quarter
Promoter Holding Up
Promoters have increased holdings from 58.10% to 58.16% in Mar 2025 quarter
Price Rise
In the last 7 days, LYKALABS stock has moved up by 3.9%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 124.2% return, outperforming this stock by 123.1%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 53.5% return, outperforming this stock by 41.1%
Retail Holding Down
Retail Investor have decreased holdings from 41.08% to 40.94% in Mar 2025 quarter
Revenue Fall
Revenue is down for the last 3 quarters, 41.18 Cr → 34.25 Cr (in ₹), with an average decrease of 8.5% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 2.7 Cr → 2.03 Cr (in ₹), with an average decrease of 24.8% per quarter
Organisation | Lyka Labs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | KUNAL NARENDRA GANDHI |
E-voting on shares | Click here to vote |
Lyka Labs share price today stands at ₹121.67, Open: ₹123.96, Previous Close: ₹123.63, High: ₹123.96, Low: ₹120.72, 52 Week High: ₹176.59, 52 Week Low: ₹96.8.
Today's traded volume of Lyka Labs is 53.53K. Which means that 53.53K shares of Lyka Labs were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Lyka Labs is ₹434.24 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Lyka Labs’s 52 week high is ₹176.59 and 52 week low is ₹96.8. The current share price of Lyka Labs is ₹121.67, which is -31.10% down from its 52 week high and 25.69% up from its 52 week low.